rfi.ac.uk 的前十大競爭對手

rosalindfranklin.edu

The School of Graduate and Postdoctoral Studies provides academic programs leading to a variety of advanced degrees in biomedical sciences. PhD and Masters’ de

ses.ai

SES AI specializes in developing and manufacturing high-performance lithium-metal rechargeable batteries for electric vehicles and various other applications.

ptcbio.com

What is Huntington’s Disease? Huntington’s disease is a rare, hereditary, genetic disorder of the central nervous system.1 It is caused by a defective gene. This gene produces a protein, called huntingtin, which is involved in the functioning of the nerve cells in the brain (neurons). When the gene is defective, it produces an abnormal (or mutated)…

zealandpharma.com

Zealand Pharma is a biotechnology company dedicated to developing innovative peptide-based medicines for people living with unmet medical needs

leibniz-fmp.de

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the Faculty of Medicine at Kiel University, and the Leibniz Institute of Virology in Hamburg are jointly receiving funding of nearly one million euros as part of the "Leibniz Cooperative Excellence" program. The goal of the project is to unravel fundamental mechanisms of two-pore domain potassium channels (K2P channels) – with potential new therapeutic approaches for cancer, autoimmune diseases, infectious diseases, central nervous system disorders, and cardiovascular diseases.

nottinghambrc.nihr.ac.uk

the nottingham biomedical research centre (brc) is improving the health of millions of people with common diseases like asthma, depression and arthritis.

cimus.usc.gal

the center for research in molecular medicine and chronic diseases (cimus) is a member of the singular research centers network, a core structure of the campus of international excellence– campus vida project, university of santiago de compostela.

omrf.org

Discovery upends conventional wisdom about cellular interactions

hansabiopharma.com

We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.

innoprot.com

Alveolar Epithelial Cell Medium-SPC+ is a complete medium designed for optimal growth of normal primary type II alveolar epithelial cells in vitro.